Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population Minkyo SongM. Constanza CamargoCharles S. Rabkin Original Article 17 February 2018 Pages: 729 - 737
Predictors of heterogeneity in the first-line treatment of patients with advanced/metastatic gastric cancer in the U.S. Thomas AbramsLisa M. HessCharles Fuchs Original Article 01 February 2018 Pages: 738 - 744
Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication Masahiro MaedaSatoshi YamashitaToshikazu Ushijima Original Article 09 February 2018 Pages: 745 - 755
HOTAIR induces the ubiquitination of Runx3 by interacting with Mex3b and enhances the invasion of gastric cancer cells Meng XueLu-yi ChenShu-jie Chen Original Article 07 February 2018 Pages: 756 - 764
Molecular profiling and comprehensive genome-wide analysis of somatic copy number alterations in gastric intramucosal neoplasias based on microsatellite status Tamotsu SugaiMakoto EizukaHiromu Suzuki Original Article Open access 21 February 2018 Pages: 765 - 775
Quantitative assessment of fluorescence intensity of ICG in sentinel nodes in early gastric cancer Keishi OkuboYoshikazu UenosonoShoji Natsugoe Original Article 07 March 2018 Pages: 776 - 781
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer Zhihao LuXiaotian ZhangLin Shen Original Article Open access 27 February 2018 Pages: 782 - 791
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study Akitaka MakiyamaKenji KuniedaTaito Esaki Original Article 20 January 2018 Pages: 792 - 801
Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11 Hyeong Su KimMin-Hee RyuYoon-Koo Kang Original Article 25 January 2018 Pages: 802 - 810
A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial Kazuhiro NishikawaAkira TsuburayaJunichi Sakamoto Original Article 27 February 2018 Pages: 811 - 818
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG) Minkyu JungMin-Hee RyuYoon-Koo Kang Original Article 09 February 2018 Pages: 819 - 830
Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices A. Scott PaulsonLisa M. HessWilliam Schelman Original Article 03 February 2018 Pages: 831 - 844
Total vs proximal gastrectomy for adenocarcinoma of the upper third of the stomach: a propensity-score-matched analysis of a multicenter western experience (On behalf of the Italian Research Group for Gastric Cancer–GIRCG) Fausto RosaGiuseppe QueroSergio Alfieri Original Article 08 February 2018 Pages: 845 - 852
Which method is more suitable for advanced gastric cancer with enlarged lymph nodes, laparoscopic radical gastrectomy or open gastrectomy? Qi-Yue ChenChao-Hui ZhengChang-Ming Huang Original Article 30 January 2018 Pages: 853 - 863
Clinical outcomes of intraoperative manual dilatation of pylorus in pylorus-preserving gastrectomy: a retrospective analysis Chun-Chao ZhuTae-Han KimHan-Kwang Yang Original Article 13 March 2018 Pages: 864 - 870
Two-point measurement of amylase in drainage fluid predicts severe postoperative pancreatic fistula after gastric cancer surgery Satoshi KamiyaNaoki HikiToshiharu Yamaguchi Original Article 13 February 2018 Pages: 871 - 878
Preliminary opinion on assessment categories of stomach ultrasound report and data system (Su-RADS) Zhining LiuWeidong RenZhijun Liu Technical Note Open access 25 January 2018 Pages: 879 - 888
